NASDAQ · EYPT
EyePoint, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for EYPT: Nov 4, 2026
EyePoint, Inc. Common Stock is estimated to report earnings on 11/04/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 4 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.88. The reported EPS for the same quarter last year was $-0.85.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.88 | $-0.79 | $-0.95 | 4 |
| Dec 2026 | $-0.59 | $-0.36 | $-0.87 | 4 |
| Mar 2027 | $-0.38 | $-0.28 | $-0.48 | 2 |
| Jun 2027 | $-0.36 | $-0.25 | $-0.46 | 2 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · RTTNews · BNK Invest · Barchart- Zacks · Oct 28, 9:00 AM EDTEyePoint (EYPT) Expected to Beat Earnings Estimates: Should You Buy?EyePoint (EYPT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- RTTNews · Oct 23, 10:53 AM EDTWeekly Buzz: AZN, ALVO Score FDA Nod; EYPT Cuts Jobs; RHHBY, GEHC Enter Deal; VERA Posts Trial Win(RTTNews) – Healthcare and biotech news this week centred on regulatory approvals, strategic deals, and pivotal clinical data.
- BNK Invest · Oct 19, 4:30 PM EDTNotable Monday Option Activity: EYPT, ABM, ORCLAmong the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in EyePoint Inc (Symbol: EYPT), where a total of 30,668 contracts have traded so far, representing approximately 3.1 million underlying shares. That amounts to about 109.1%
- RTTNews · Oct 19, 8:30 AM EDTEyePoint's DURAVYU Misses Primary Goal Despite Reduced Treatment Burden; Stock Down(RTTNews) – EyePoint, Inc. (EYPT), a clinical-stage biopharmaceutical company developing treatments for serious retinal diseases, announced topline results from LUCIA, the second pivotal Phase 3 trial evaluating DURAVYU (vorolanib intravitreal insert) for wet age-related macular
- RTTNews · Oct 19, 8:25 AM EDTEyePoint's DURAVYU Misses Primary Endpoint In Phase 3 Wet AMD Trial(RTTNews) – EyePoint (EYPT) reported that DURAVYU failed to meet the primary endpoint in the Phase 3 LUCIA trial for wet age-related macular degeneration (AMD).
- Zacks · Oct 15, 10:04 AM EDTHere's Why You Should Add EYPT Stock to Your Portfolio NowEyePoint's Duravyu faces a key LUCIA study data readout in late 2026, with results potentially paving the way for an NDA filing in 2027.
- RTTNews · Aug 21, 10:17 AM EDTWeekly Buzz: RARE, REGN Secure FDA Nod, BMRN Stikes Deal; HUMA, EYPT Face Trial Setbacks(RTTNews) – This week's global biopharma roundup captured a mix of regulatory approvals, strategic partnerships, acquisitions, and merger activity, alongside clinical trial breakthroughs and halts. Positive readouts across autoimmune myositis, glioma, and melanoma were offset by
- Barchart · Aug 18, 2:47 PM EDTStocks Settle Lower on Rising Crude Prices and Higher Bond YieldsThe S&P 500 Index ($SPX ) (SPY ) closed down by -0.52% on Monday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down by -0.51%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.17%. E-mini S&P futures (ESU26 ) fell -0.48%, and September E-mini…
- BNK Invest · Aug 18, 10:40 AM EDTEYPT November 20th Options Begin TradingInvestors in EyePoint Inc (Symbol: EYPT) saw new options begin trading today, for the November 20th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 94 days until expiration the newly trading contracts repr
- Zacks · Aug 18, 10:33 AM EDTEYPT Stock Plunges 67% After Duravyu Misses Phase III Eye Disease GoalEyePoint's Duravyu misses the phase III wet AMD study's primary goal, sending shares down 67%, but shows lower treatment burden and durable disease control.
- Barchart · Aug 17, 7:28 PM EDTStock Indices Waver on Strength in Chipmakers vs Weakness in Software CompaniesThe S&P 500 Index ($SPX ) (SPY ) is down by -0.15% today, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down by -0.44%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up by +0.28%. E-mini S&P futures (ESU26 ) are down -0.17%, and September E-mini…
- Barchart · Aug 17, 6:26 PM EDTStocks Mixed on Strength in Chipmakers vs Weakness in Software CompaniesThe S&P 500 Index ($SPX ) (SPY ) is up by +0.17% today, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up by +0.20%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up by +0.13%. E-mini S&P futures (ESU26 ) are up +0.05%, and September E-mini…
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for EyePoint, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.